Compare DOLE & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DOLE | PRGO |
|---|---|---|
| Founded | 1851 | 1887 |
| Country | Ireland | Ireland |
| Employees | 32027 | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2021 | 2013 |
| Metric | DOLE | PRGO |
|---|---|---|
| Price | $14.49 | $11.34 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 3 |
| Target Price | $15.00 | ★ $19.33 |
| AVG Volume (30 Days) | 861.5K | ★ 2.2M |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | 2.29% | ★ 10.28% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $9,172,907,000.00 | $800,000.00 |
| Revenue This Year | $4.93 | N/A |
| Revenue Next Year | $1.72 | $1.02 |
| P/E Ratio | $44.18 | ★ N/A |
| Revenue Growth | ★ 8.23 | N/A |
| 52 Week Low | $12.52 | $9.23 |
| 52 Week High | $16.51 | $28.44 |
| Indicator | DOLE | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 46.44 | 52.01 |
| Support Level | $13.82 | $11.26 |
| Resistance Level | $15.48 | $12.36 |
| Average True Range (ATR) | 0.52 | 0.50 |
| MACD | -0.04 | -0.05 |
| Stochastic Oscillator | 35.03 | 40.29 |
Dole PLC operates in the North American and European markets for fresh fruits and vegetables. The company's segment includes Fresh Fruit; Diversified Fresh Produce - EMEA; Diversified Fresh Produce - Americas and ROW. It generates maximum revenue from the Diversified Fresh Produce - EMEA segment. Diversified Fresh Produce - EMEA segment includes Dole's Irish, Dutch, Spanish, Portuguese, French, Italian, U.K., Swedish, Danish, South African, Eastern European, and Brazilian businesses, the majority of which sell a variety of imported and local fresh fruits and vegetables through retail, wholesale and, in some instances, food service channels across the European marketplace. Geographically, the company operates in United States, Ireland, U.K. Spain, Sweden, and Others.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.